Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease

Ultrasound Med Biol. 2020 Apr;46(4):972-980. doi: 10.1016/j.ultrasmedbio.2019.12.020. Epub 2020 Jan 29.

Abstract

In this study, we evaluated the diagnostic accuracy of shear wave elastography (SWE) for differentiating high-risk non-alcoholic steatohepatitis (hrNASH) from non-alcoholic fatty liver and low-risk non-alcoholic steatohepatitis (NASH). Patients with non-alcoholic fatty liver disease scheduled for liver biopsy underwent pre-biopsy SWE. Ten SWE measurements were obtained. Biopsy samples were reviewed using the NASH Clinical Research Network Scoring System and patients with hrNASH were identified. Receiver operating characteristic curves for SWE-based hrNASH diagnosis were charted. One hundred sixteen adult patients underwent liver biopsy at our institution for the evaluation of non-alcoholic fatty liver disease. The area under the receiver operating characteristic curve of SWE for hrNASH diagnosis was 0.73 (95% confidence interval: 0.61-0.84, p < 0.001). The Youden index-based optimal stiffness cutoff value for hrNASH diagnosis was calculated as 8.4 kPa (1.67 m/s), with a sensitivity of 77% and specificity of 66%. SWE may be useful for the detection of NASH patients at risk of long-term liver-specific morbidity and mortality.

Keywords: High-risk non-alcoholic steatohepatitis; Liver biopsy; Non-alcoholic steatohepatitis; Shear wave elastography.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers
  • Biopsy, Large-Core Needle
  • Elasticity Imaging Techniques / methods*
  • Female
  • Humans
  • Liver / diagnostic imaging*
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / diagnosis
  • Non-alcoholic Fatty Liver Disease / diagnostic imaging*
  • Reproducibility of Results
  • Sensitivity and Specificity

Substances

  • Biomarkers